Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Prostate (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02362464
What this trial is testing

Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

Who this might be right for
Prostatic NeoplasmsNeoplasms of ProstateProstate Cancer+2 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Ended earlyNCT00444639
What this trial is testing

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

Who this might be right for
Prostate Cancer
Ipsen 25
Not applicableStudy completedNCT01696539
What this trial is testing

Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients

Who this might be right for
Prostatic Neoplasm
Örebro University, Sweden 42
Not applicableStudy completedNCT03675529
What this trial is testing

The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.

Who this might be right for
Prostate Cancer
Rigshospitalet, Denmark 30
Not applicableStudy completedNCT03776045
What this trial is testing

PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)

Who this might be right for
Prostate Cancer
University of East Anglia 50
Not applicableStudy completedNCT00719030
What this trial is testing

The Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT05059236
What this trial is testing

Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer
Bayer 223
Not applicableLooking for participantsNCT07093177
What this trial is testing

Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of Utah 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06734130
What this trial is testing

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 25
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Testing effectiveness (Phase 2)Study completedNCT01227642
What this trial is testing

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

Who this might be right for
Clinical Stage T2b or Less of Prostate CancerProstate BrachytherapyTransrectal Prostate Ultrasound Treatment Planning
Beth Israel Medical Center 14
Not applicableActive Not RecruitingNCT03381105
What this trial is testing

From PSA to Stockholm3: Study Part 1

Who this might be right for
Prostate Cancer
Helse Stavanger HF 13,431
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Not applicableStudy completedNCT02425228
What this trial is testing

Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer

Who this might be right for
Elevated PSAProstate Cancer
Jonsson Comprehensive Cancer Center 300
Testing effectiveness (Phase 2)Study completedNCT00126165
What this trial is testing

Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alberta Health services 72
Not applicableStudy completedNCT04516707
What this trial is testing

Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO

Who this might be right for
Prostate CancerBone MetastasesHormone-resistant Prostate Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 67
Testing effectiveness (Phase 2)Study completedNCT03043807
What this trial is testing

Definitive Therapy to Treat Prostate Cancer After Prostatectomy

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Large-scale testing (Phase 3)Study completedNCT00134056
What this trial is testing

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
SWOG Cancer Research Network 1,038
Next Page